TITLE

Random sampling and allocation using SPSS

AUTHOR(S)
Arifin, Wan Nor
PUB. DATE
June 2012
SOURCE
Education in Medicine Journal;Jun2012, Vol. 4 Issue 1, pe129
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Among the most important aspects in conducting a clinical trial are random sampling and allocation of subjects. The processes could be easier if done with familiar software used for data entry and analysis instead of relying on other programs or methods. The objective of this article is to demonstrate random sampling and allocation using SPSS in step-by-step manners using examples most relevant to clinicians as well as researchers in health sciences.
ACCESSION #
83431487

 

Related Articles

  • CE/CMEquestions.  // Clinical Trials Administrator;Mar2008, Vol. 6 Issue 3, p36 

    A multiple choice quiz based on articles published within the issue is presented.

  • Estech begins enrollment in HISTORIC-AF study.  // Medical Device Daily;12/7/2011, Vol. 15 Issue 233, p7 

    The article reports on the enrollment of the first three patients in the HISTORIC-AF European multi-center staged hybrid ablation clinical study by Estech.

  • Young cancer patients should have option to be part of clinical trials.  // Nursing Children & Young People;Mar2014, Vol. 26 Issue 2, p7 

    The article cites recommendation by England's National Institute for Health and Care Excellence that children and young people with cancer must have the opportunity to participate in clinical trials to increase knowledge and improve survival rates.

  • UK must improve its recruitment rate in clinical trials, report says. Hawkes, Nigel // BMJ: British Medical Journal;12/1/2012, Vol. 345 Issue 7885, p5 

    The article reports that according to a report produced for the drug company Novartis, poor recruitment and lengthy negotiations escalate the cost of clinical trials in the Great Britain compared to other European countries.

  • Clinical trials on trial: Underserved patients, institutional frustrations complicate research efforts. Harris, Jason // Hem/Onc Today;10/25/2011, Vol. 12 Issue 20, p1 

    The article discusses the findings of surveys which revealed factors that impede patients to participate in clinical trials, thus, complicating research efforts, and the role of physicians to encourage patients to participate in such trials.

  • Alternatives to parallel group design suggested for trials.  // British Journal of Hospital Medicine (17508460);2015, Vol. 76 Issue 7, p383 

    The article reports on the research on alternatives to parallel group design suggested for trials to make it cheaper and easier to run, referencing a study by R. Hooper and L. Bourke published in a 2015 issue of "British Medical Journal."

  • Why we need to redefine the "team" in rare disease trials. Frakes, David // CenterWatch Monthly;Dec2016, Vol. 23 Issue 12, p6 

    The article discusses the need to consider the broader team of stakeholders which includes the patients, their caregivers and their physicians during the clinical study design phase for rare diseases to understand patient experience and to achieve a successful clinical trial.

  • Randomized Clinical Trial of manual static stretch and massage of the feet and ankle joints on balance of male elderlies. H., Safakheil; R., Olyaei G.; M., Abdolvahab; P., Raji; B., Attarbashi; A., Baghestani; A., Molaee // Modern Rehabilitation;2013, Vol. 7 Issue 3, p1 

    Background and Aim: Improving the affecting factors of balance could be a critical procedure in managing the elderly's balance dysfunction. The goal of this study is to find out how and to which amount a prolonged period of stretch and massage impact on elderly's balance. Materials and Methods:...

  • Prognostic analysis of Chinese patients with metastasis renal cell cancer receiving sorafenib: results from a multicenter long-term follow-up retrospective study. Fang Guo; Tao Han; Zhaozhe Liu; Xishuang Song; Qifu Zhang; Xiangbo Kong; Changfu Li; Zhenhua Li; Chengge Li; Shuxian Qu; Zhendong Zheng; Ying Piao; Yaling Han; Xiaodong Xie // OncoTargets & Therapy;2015, Vol. 8, p1581 

    The effects of sorafenib for Chinese patients with metastatic renal cell cancer (mRCC) were evaluated to figure out the relationship between clinical variables and prognosis. The data were analyzed retrospectively from six comprehensive cancer centers in Northeast China. All cases were diagnosed...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics